Treace Medical Concepts to Showcase Innovations at Healthcare Conference
Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI) is gearing up to highlight its pioneering role in the surgical treatment of bunions and related midfoot deformities. The company’s flagship product, Lapiplasty, has transformed the approach to treating these conditions by addressing their root causes instead of merely alleviating the symptoms.
Fireside Chat Scheduled at Morgan Stanley Event
John T. Treace, the Chief Executive Officer, along with Mark L. Hair, the Chief Financial Officer of Treace, will take part in a fireside chat at the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference. This discussion is set to kick off around 10:00 am ET.
Details on the Webcast
A live webcast of this insightful conversation will be available on the Company’s investor relations website. This platform will enable investors and stakeholders to engage with the discussion and stay updated on the latest developments and strategies from the Company.
Dedication to Investor Relations
Treace offers a valuable resource for investors through its investor relations section on the Company’s website. The Company is committed to providing essential updates and insights, ensuring that both current and potential shareholders are well-informed about its performance and market strategies.
Significance of Information Updates
Investors are encouraged to regularly visit the Treace website for important announcements and information that may influence their investment choices. Timely dissemination of information is a vital part of the Company’s strategy to engage with its investors.
Transforming Surgical Care for Bunions
Treace Medical Concepts is focused on improving the standard of care in the surgical management of bunions and other midfoot deformities. Each year, around 1.1 million Americans undergo surgery for bunion deformities, highlighting the pressing need for effective treatment options.
Innovative Solutions Offered by Treace
To comprehensively tackle bunion issues, Treace has created the Lapiplasty® 3D Bunion Correction® System. This patented system combines various instruments, implants, and surgical techniques specifically designed to correct bunions in three dimensions. The goal is to stabilize the affected joint, allowing patients to return to their active lifestyles quickly.
Addressing Midfoot Deformities
In addition, Treace has launched the Adductoplasty® Midfoot Correction System. This innovative solution is tailored for the consistent surgical correction of midfoot deformities. The introduction of SpeedPlate™ Rapid Compression Implants further enhances the Company’s offerings, providing an advanced fixation platform that increases surgical versatility.
Plans for Market Expansion
With the introduction of these groundbreaking technologies, Treace aims to broaden its market presence in the foot and ankle sector. By continually innovating and enhancing its product line, Treace is determined to maintain a leading position in the medical technology industry focused on treating foot-related conditions.
Connect with Treace Medical Concepts
For more information about Treace Medical Concepts and its range of offerings, interested individuals are encouraged to visit their official website. Comprehensive details about their products, company news, and resources for investors are readily available. Engaging with Treace on social media platforms like LinkedIn, X, Facebook, and Instagram provides a deeper understanding of their commitment to improving surgical outcomes for patients.
Contact Information
For any inquiries, individuals can reach out to Treace Medical Concepts directly using the contact details provided below:
Contacts:
Mark L. Hair
Chief Financial Officer
Email: mhair@treace.net
Phone: (904) 373-5940
Investors:
Vivian Cervantes
Email: IR@treace.net
Frequently Asked Questions
What is Treace Medical Concepts known for?
Treace Medical Concepts specializes in medical technology focused on treating bunions and midfoot deformities, providing advanced surgical solutions.
When will Treace participate in the Morgan Stanley Conference?
The Company is set to participate in a fireside chat scheduled for approximately 10:00 am ET.
How can investors access the webcast?
Investors can access the live webcast through the investor relations section of the Treace Medical Concepts website.
What systems has Treace developed for bunion treatment?
Treace has developed the Lapiplasty® 3D Bunion Correction® System and the Adductoplasty® Midfoot Correction System.
How does Treace support its investors?
Treace supports its investors by regularly posting relevant information on their website and engaging with them through social media channels.